Subway riders walk through the turnstiles while leaving the U.S. Open in New York September 4, 2007. (Lucas Jackson/Reuters)Reuters - Sanofi-Aventis won a final green light for its obesity drug Acomplia from Britain's cost-effectiveness watchdog NICE on Wednesday, clearing the way for doctors to prescribe it on the state health service.


This entry was posted on Wednesday, June 25th, 2008 at 9:23 am and is filed under Weight Loss News.